Dr. Carol H. Wysham interviews AACE President, Scott D. Isaacs, MD, FACP, FACE, on the Medscape InDiscussion: Type 2 Diabetes (Season 3) podcast to discuss the screening and management of metabolic dysfunction–associated steatotic liver disease (MASLD) in endocrine practice. Tune in to learn why MASLD is considered the hepatic complication of type 2 diabetes, the importance of FIB-4 screening, and how to optimize patient care with GLP-1s, SGLT2s, and emerging therapies. Plus, explore the critical role of lifestyle interventions in managing MASLD and reducing cardiovascular risk.